COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,140 Articles (22,693 medRxiv, 8,447 bioRxiv)

Most recent first Previous |  Page 279: Articles 2781-2790  | Next

Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalization and ICU admission, the Netherlands, 9 October - 5 December 2023
van Werkhoven, H., Valk, A.-W., Smagge, B., de Melker, H. E., Knol, M. J., Hahne, S., van den Hof, S., de Gier, B.
10.1101/2023.12.12.23299855 — Posted: 2023-12-13
Impact of the population age, testing and vaccination levels on the numbers of COVID-19 cases and deaths per capita and case fatality risks
Nesteruk, I.
10.1101/2023.12.09.23299758 — Posted: 2023-12-13
Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults
Oyegun, E. I.
10.1101/2023.12.11.23299148 — Posted: 2023-12-13
The impact of COVID-19 vaccines on patients with immune thrombocytopenic purpura:A protocol for a systematic review and meta-analysis
Li, Y., Kong, D., Ding, Y., Wang, J.
10.1101/2023.12.09.23298879 — Posted: 2023-12-13
Syncytia Formation Promotes Virus Resistance to Interferon and Neutralizing Antibodies
Li, T., Kang, I., Hu, Z., Gibbs, J., Ye, C., Kosik, I., Shi, G., Holly, J., Kosikova, M., Compton, A. A., Martinez-Sobrido, L., Johnson, R., Hang, X., Yewdell, J. W.
10.1101/2023.12.12.571262 — Posted: 2023-12-13
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Lee, J., Stewart, C., Schaefer, A., Leaf, E. M., Park, Y.-J., Asarnow, D., Powers, J. M., Treichel, C., Corti, D., Baric, R., King, N. P., Veesler, D.
10.1101/2023.12.12.571160 — Posted: 2023-12-13
G6PD deficiency mediated impairment of iNOS and lysosomal acidification affecting phagocytotic clearance in microglia in response to SARS-CoV-2
Mondal, A., Munan, S., Saxena, I., Mukherjee, S., Upadhyay, P., Gupta, N., Dar, W., Samanta, A., Singh, S., Pati, S.
10.1101/2023.12.12.570971 — Posted: 2023-12-12
SARS-CoV-2 nsp15 preferentially degrades AU-rich dsRNA via its dsRNA nickase activity
Wang, X., Zhu, B.
10.1101/2023.12.11.571056 — Posted: 2023-12-12
The complement pattern recognition molecule CL-11 promotes invasion and injury of respiratory epithelial cells by SARS-CoV-2.
Polycarpou, A., Wagner-Gamble, T., Greenlaw, R., O'Neill, L. A., Khan, H., Malim, M. M., Romano, M., Smolarek, D., Doores, K. J., Wallis, R., Klavinskis, L. S., Sacks, S.
10.1101/2023.12.11.571109 — Posted: 2023-12-12
AlphaFold2-Enabled Atomistic Modeling of Epistatic Binding Mechanisms for the SARS-CoV-2 Spike Omicron XBB.1.5, EG.5 and FLip Variants: Convergent Evolution Hotspots Cooperate to Control Stability and Conformational Adaptability in Balancing ACE2 Binding and Antibody Resistance
Raisinghani, N., Alshaharani, M., Gupta, G., Xiao, S., Tao, P., Verkhivker, G.
10.1101/2023.12.11.571185 — Posted: 2023-12-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).